Effect of Intravenous Cyclophosphamide Pulse Therapy on Renal Functions and Histopathology in Patients with Severe Lupus Nephritis

Effect of Intravenous Cyclophosphamide Pulse Therapy on Renal Functions and Histopathology in Patients with Severe Lupus Nephritis

Despite the wide use of intravenous cyclophosphamide (IC) in lupus nephritis (LN), there are few published studies showing the effect of this treatment on renal histology. In this prospective study, we report the effect of IC on the evolution of histopathologic features in successive renal biopsies...

Full description

Bibliographic Details
Main Authors:	Huraib Sameer, Abu-Aisha Hassan, Memon Nawaz, Al-Wakeel Jamal, Al Ballaa Suliman, Mitwalli Ahmed, Alam Awatif, Al Sohabani Mohamed, Askar Akram
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2000-01-01
Series:	Saudi Journal of Kidney Diseases and Transplantation
Subjects:	Lupus nephritis Cyclophosphamide Pulse therapy Renal histology.
Online Access:	http://www.sjkdt.org/article.asp?issn=1319-2442;year=2000;volume=11;issue=2;spage=167;epage=173;aulast=Huraib

Similar Items

TO COMPARE THE EFFICACY OF MYCOPHENOLATEMOFETYL WITH CYCLOPHOSPHAMIDE IN THE MANAGEMENT OF LUPUS NEPHRITIS
by: Dilshad Muhammad, et al.
Published: (2014-12-01)

Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide
by: Li Zhang, et al.
Published: (2020-07-01)

Comparison of mycophenolic acid with cyclophosphamide for the treatment of pediatric lupus nephritis: A retrospective study from a tertiary center hospital in Taiwan
by: Huei-Geng Chen, et al.
Published: (2023-10-01)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01)

SEVERE HYPONATREMIA, HYPERTENSION, ACUTE DETERIORATION OF RENAL FUNCTION IN A YOUNG FEMALE WITH LUPUS NEPHRITIS
by: Ioana Saulescu, et al.
Published: (2017-12-01)

Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation
by: Yan JIANG, et al.
Published: (2020-05-01)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
by: Xiaohui Zhang, et al.
Published: (2023-07-01)

Fish oil enhanced the efficacy of low-dose cyclophosphamide regimen for proliferative lupus nephritis: a randomized controlled double-blind trial
by: Chi Zhang, et al.
Published: (2021-07-01)

Comparison of high and low dose of cyclophosphamide in lupus nephritis patients: A long-term randomized controlled trial
by: Ahmed H Mitwalli, et al.
Published: (2011-01-01)

Long-Term Outcome of Patients with Lupus Nephritis: A Single Center Experience
by: Senija Rašić, et al.
Published: (2010-04-01)

Lupus nephritis - case report of an uncommon succession of therapies
by: Andreea Rovinaru, et al.
Published: (2023-12-01)

Protective effects of crocin on testes of adult cyclophosphamide treated mice
Published: (2014-04-01)

The effect of vitamin E on the histological structure of kidney in rats treated with cyclophosphamide
by: Ahmed A. Obaid, et al.
Published: (2022-04-01)

Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria
by: Kristina Vollbach, et al.
Published: (2022-04-01)

Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies
by: Tak Mao eChan, et al.
Published: (2015-09-01)

Comparison of iguratimod and conventional cyclophosphamide with sequential azathioprine as treatment of active lupus nephritis: study protocol for a multi-center, randomized, controlled clinical trial (iGeLU study)
by: Qingran Yan, et al.
Published: (2021-08-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis
by: Yen Yen Ari Indrawijaya, et al.
Published: (2023-07-01)

Sesamin’s Therapeutic Actions on Cyclophosphamide-Induced Hepatotoxicity, Molecular Mechanisms, and Histopathological Characteristics
by: Abdulmajeed M. Jali, et al.
Published: (2023-12-01)

Renalase and lupus nephritis: disease activity and histopathological classification
by: Marwa Y Mahgoub, et al.
Published: (2018-01-01)

Histopathological study of lupus nephritis with special reference to nonlupus nephritis, focal segmental glomerulosclerosis, interstitial nephritis, and amyloidosis
by: Usha Singh, et al.
Published: (2016-01-01)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
by: Xuebing Zhang, et al.
Published: (2020-11-01)

Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis
by: Jennifer C Cooper, et al.
Published: (2018-10-01)

Comparison of oral and intravenous cyclophosphamide in children with steroid-resistant nephrotic syndrome
by: Eka Laksmi Hidayati, et al.
Published: (2011-10-01)

Protective effect of Concurrent Administration of Mesna and Galbanum Oil on Histological Structure of Rat Placenta against Cyclophosphamide Toxicity
by: Tayebeh Mohammadi, et al.
Published: (2016-07-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

Lupus nephritis : frontiers and challenges /
by: Sheashaa, Hussein A.
Published: (2010)

Combination Therapy With Pulse Cyclophosphamide Plus Corticosteroids Improves Renal Outcome In Patients With Lupus Nephritis
by: H. Mansouri Torghabeh, et al.
Published: (2005-08-01)

Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna
by: M.M. Morais, et al.
Published: (1999-10-01)

Exhausted but Not Senescent T Lymphocytes Predominate in Lupus Nephritis Patients
by: Georgios Lioulios, et al.
Published: (2022-11-01)

Naringenin ameliorates Cyclophosphamide-induced nephrotoxicity in experimental model
by: Nouf K. Alaqeel, et al.
Published: (2023-06-01)

A Histology-Guided Approach to the Management of Patients with Lupus Nephritis: Are We There Yet?
by: Bogdan Obrișcă, et al.
Published: (2022-06-01)

A multisystem syndrome compatible with systemic lupus erythematosus: Case report and review of literature
by: Samira Alesaeidi, et al.
Published: (2021-07-01)

Circulating serum anti-C1q antibody: Correlation with clinical and histopathological activity in patients with proliferative lupus nephritis
by: Amer A Abeed, et al.
Published: (2016-01-01)

Lupus Nephritis among Arabs - Differences with other Races; Emphasis on Clinicopathological and Serological Perspectives
by: Al Attia Haider
Published: (2000-01-01)

Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Schönlein purpura)-related nephritis: a cohort in the adult Chinese population
by: Xiao Huang, et al.
Published: (2018-11-01)

Shunt nephritis
by: Viviana Parra I, et al.
Published: (2014-05-01)

Evaluation of histological changes induced by prednisolone and cyclophosphamide in some organs of male albino mice
by: Sahar A AL-Sharqi, et al.
Published: (2022-06-01)

Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies
by: Irmak Karaca, et al.
Published: (2024-03-01)

Effect of Lycopene on Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats
by: Akram Jamshidzadeh, et al.
Published: (2009-03-01)